Clinical trial

Study Assessing The Interest of Indocyanine Green Fluorescence Imaging With Radioisotope Method For Sentinel Lymph Node Biopsy in Patients With Breast Cancer

NCT02279108

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-11-01

PhasePHASE3

Study timeline

Study start (actual)2014-11-01Date precision: month

Registry last updated2018-04-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Neoplasmsunresolved

Interventions

indocyanine greenDRUG · verified · RxNorm: indocyanine green

isotopeDRUG

Sponsors & collaborators

Centre Hospitalier Universitaire de Saint Etiennelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02279108 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.